Mostrar el registro sencillo del ítem

dc.creatorMartínez-Vélez, Nora Angélicaes_ES
dc.creatorTiburcio, Marcelaes_ES
dc.creatorNatera Rey, Guillerminaes_ES
dc.creatorVillatoro Velázquez, Jorge Amethes_ES
dc.creatorArroyo-Belmonte, Miriames_ES
dc.creatorSánchez-Hernández, Graciela Yazmínes_ES
dc.creatorFernández-Torres, Morisees_ES
dc.date2021
dc.date.accessioned2024-02-01T19:48:16Z
dc.date.available2024-02-01T19:48:16Z
dc.date.issued2021
dc.identifierJC36DIEP21es_ES
dc.identifier.urihttp://repositorio.inprf.gob.mx/handle/123456789/7904
dc.identifier.urihttps://doi.org/10.3389/fpubh.2021.709410
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419305/
dc.descriptionPeople can increase their use of psychoactive substances in response to stressful situations as a maladaptive mechanism for reducing negative affective states. It is therefore necessary to examine changes in the use of such substances and their relationship to mental health in light of the COVID-19 pandemic. Objective: Evaluate the relationship between psychoactive substances and stress, emotional state, and symptomatology during the COVID-19 lockdown in Mexico. Method: A national survey was conducted, using the free Google Forms platform, of residents of Mexico aged 18 and older. The survey was disseminated through social media. Results: The sample comprised 4,122 individuals, mostly women (71.8%), with an age range of 18-81 years (M = 37.08, SD = 12.689), of which 46.8% were single, and 42.9% married. In general, there was a reduction in substance use during the first 2 months of the quarantine; the most commonly used substances were alcohol, tobacco, and tranquilizers. Respondents who described having greater use than before the pandemic presented greater stress, depressive symptomatology, and perceived threat than those who did not use substances. Conclusions: Respondents who did not use substances reported lower levels of stress, depressive symptomatology, impact of the coronavirus pandemic, and perception of its threat. Women reported greater stress, depressive symptomatology, and emotional intensity than men.es_ES
dc.formatPDFes_ES
dc.language.isoenges_ES
dc.publisherFrontiers Editorial Officees_ES
dc.relation9:709410
dc.rightsAcceso Cerradoes_ES
dc.titlePsychoactive substance use and its relationship to stress, emotional state, depressive symptomatology, and perceived threat during the COVID-19 pandemic in Mexicoes_ES
dc.typeArtículoes_ES
dc.contributor.affiliationDepartment of Social Sciences in Health, Direction of Epidemiological and Psychosocial Research, Ramón de la Fuente Muñiz National Institute of Psychiatry, Mexico City, Mexico
dc.contributor.emailtibsam@imp.edu.mx (Marcela Tiburcio)
dc.relation.jnabreviadoFRONT PUBLIC HEALTH
dc.relation.journalFrontiers in Public Health
dc.identifier.placeSuiza
dc.date.published2021
dc.identifier.organizacionInstituto Nacional de Psiquiatría Ramón de la Fuente Muñiz
dc.identifier.eissn2296-2565
dc.identifier.doi10.3389/fpubh.2021.709410
dc.subject.kwSubstance use
dc.subject.kwMood
dc.subject.kwMental health
dc.subject.kwCOVID-19
dc.subject.kwMexico


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem